GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daewoong Pharmaceutical Co Ltd (XKRX:069620) » Definitions » Balance Sheet Cash And Cash Equivalents

Daewoong Pharmaceutical Co (XKRX:069620) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2002. Start your Free Trial

What is Daewoong Pharmaceutical Co Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Daewoong Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
12, Bongeunsa-ro 114-gil, Daewoong Pharmaceutical Building, Gangnam-gu, Seoul, KOR
Daewoong Pharmaceutical Co Ltd develops, manufactures and sells prescription drug products. The company's product portfolio comprises products such as Moxicle, Plunazol Cap, Bearcef tab, Newdizime etc. It develops and promotes brands such as Ursa, Nabota, Luphere, Easyef, Cretropin. The company has manufacturing facilities at Hyangnam and Sungnam.